Your browser doesn't support javascript.
loading
Systematic review of costs and cost-effectiveness of treatment for relapsed/refractory acute leukemia in children and young adults.
Soliman, Ranin; Heneghan, Carl; Bolous, Nancy S; Sidhom, Iman; Ahmed, Sonia; Roberts, Nia; Oke, Jason; Elhaddad, Alaa.
Afiliação
  • Soliman R; Department for Continuing Education, University of Oxford, Oxford, UK.
  • Heneghan C; Health Economics and Value Unit, Children's Cancer Hospital, Cairo, Egypt.
  • Bolous NS; Centre for Evidence Based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
  • Sidhom I; Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Ahmed S; Department of Pediatric Oncology, Children's Cancer Hospital, Cairo, Egypt.
  • Roberts N; Department of Pediatric Oncology, National Cancer Institute, Cairo University, Cairo, Egypt.
  • Oke J; Department of Pediatric Oncology, Children's Cancer Hospital, Cairo, Egypt.
  • Elhaddad A; Department of Pediatric Oncology, National Cancer Institute, Cairo University, Cairo, Egypt.
Expert Rev Hematol ; 15(4): 345-357, 2022 04.
Article em En | MEDLINE | ID: mdl-35485262

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudo: Guideline / Health_economic_evaluation / Prognostic_studies / Systematic_reviews Limite: Adult / Child / Humans Idioma: En Revista: Expert Rev Hematol Assunto da revista: HEMATOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudo: Guideline / Health_economic_evaluation / Prognostic_studies / Systematic_reviews Limite: Adult / Child / Humans Idioma: En Revista: Expert Rev Hematol Assunto da revista: HEMATOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido